Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

24 November 2025 : Clinical Research  

Perforin Expression and Natural Killer-Cell Proportion as Biomarkers in Secondary Hemophagocytic Lymphohistiocytosis

Jujuan Wang EF 1, Xin Li BE 2, Limin Duan BC 1, Guangli Yin CG 1, Xin Gao AF 1, Hongxia Qiu G 1, Ji Xu AD 1*, Tian Tian ORCID logo AB 1

DOI: 10.12659/MSM.950615

Med Sci Monit 2025; 31:e950615

Figure 4 Paired analysis of immunological parameters in patients with secondary hemophagocytic lymphohistiocytosis (sHLH) patients before and after achieving complete response (CR). Longitudinal data from 6 sHLH patients who achieved CR are shown, comparing immunological markers at initial diagnosis (sHLH) and post-treatment (CRsHLH). Each line connects the measurements from a single patient at the 2 time points. The analysis includes proportions of CD8+ T cells, NK cells, and CD56+ T cells (A), as well as the percentage of perforin-expressing cells within each of these subsets (B). A significant decrease was observed in the proportion of CD8+ T cells following treatment (P=0.0028). No other parameters showed statistically significant changes (P>0.05). Statistical significance was determined using the Wilcoxon signed-rank test for paired samples. Figure created with GraphPad Prism v8.0.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750